Cargando…
Hydroxychloroquine inhibits CD154 expression in CD4(+) T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling
BACKGROUND: Overexpression of membranous CD154 in T lymphocytes has been found previously in systemic lupus erythematosus (SLE). Because hydroxychloroquine (HCQ) has been used frequently in the treatment of lupus, we sought to identify the effects of HCQ on CD154 and a possibly regulatory mechanism....
Autores principales: | Wu, Shu-Fen, Chang, Chia-Bin, Hsu, Jui-Mei, Lu, Ming-Chi, Lai, Ning-Sheng, Li, Chin, Tung, Chien-Hsueh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550984/ https://www.ncbi.nlm.nih.gov/pubmed/28793932 http://dx.doi.org/10.1186/s13075-017-1393-y |
Ejemplares similares
-
CD154: An Immunoinflammatory Mediator in Systemic Lupus Erythematosus and Rheumatoid Arthritis
por: Alaaeddine, Nada, et al.
Publicado: (2012) -
Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis
por: Tung, Chien-Hsueh, et al.
Publicado: (2017) -
IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter
por: Lowe, RM, et al.
Publicado: (2014) -
Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
por: Lai, Jenn-Haung, et al.
Publicado: (2019) -
NFAT2 Regulates Generation of Innate-Like CD8(+) T Lymphocytes and CD8(+) T Lymphocytes Responses
por: Pachulec, Emilia, et al.
Publicado: (2016)